Sanofi SNY
NASDAQ SNY
$42.48 -0.66 (-1.53%)
At close: Sep 18, 2026 · 4:00 PM EDT

Sanofi (SNY) Income towards Parent Company (2009 - 2026)

Sanofi's (SNY) quarterly Income towards Parent Company came in at $398.7 million in Q2 2026, down 91.06% year-over-year from $4.5 billion in Q2 2025, and down 78.9% quarter-over-quarter from $1.9 billion in Q1 2026.

Analysis

Sanofi (SNY) Income towards Parent Company (2009 - 2026) Analysis & Trends

Sanofi has disclosed Income towards Parent Company across 18 years of filings, most recently posting $398.7 million for Q2 2026.

  • In Q2 2026, Income towards Parent Company fell 91.06% year-over-year to $398.7 million; the TTM figure through Jun 2026 stood at $4.7 billion (down 53.64% YoY), while the FY2025 annual figure was $9.1 billion, up 51.13% from the prior year.
  • Income towards Parent Company came in at $398.7 million for Q2 2026 at Sanofi, down from $1.9 billion in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $10.1 billion in Q3 2025 to a low of -$7.7 billion in Q4 2025.
  • Average Income towards Parent Company over 5 years is $1.9 billion, with a median of $1.9 billion recorded in 2025.
  • The largest YoY upside for Income towards Parent Company was 272.1% in 2025 against a maximum downside of 1543.62% in 2025.
  • Over 5 years, Income towards Parent Company stood at $5.4 billion in 2022, then tumbled by 111.13% to -$597.1 million in 2023, then surged by 189.3% to $533.2 million in 2024, then tumbled by 1543.62% to -$7.7 billion in 2025, then surged by 105.18% to $398.7 million in 2026.
  • Per Business Quant data, the three most recent Income towards Parent Company figures were $398.7 million in Q2 2026, $1.9 billion in Q1 2026, and -$7.7 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 398.69 Mn
Mar 31, 2026 1.89 Bn
Dec 31, 2025 -7.70 Bn
Sep 30, 2025 10.07 Bn
Jun 30, 2025 4.46 Bn
Mar 31, 2025 1.97 Bn
Dec 31, 2024 533.23 Mn
Sep 30, 2024 3.09 Bn
Jun 30, 2024 1.20 Bn
Mar 31, 2024 1.23 Bn
Dec 31, 2023 -597.15 Mn
Sep 30, 2023 2.75 Bn
Jun 30, 2023 1.56 Bn
Mar 31, 2023 2.14 Bn
Dec 31, 2022 5.37 Bn
Sep 30, 2022 2.09 Bn
Jun 30, 2022 1.25 Bn
Mar 31, 2022 2.25 Bn
Dec 31, 2021 5.80 Bn
Sep 30, 2021 2.72 Bn